Metabolism of Inhaled Corticosteroids in Human Lung Tissue
Author Information
Author(s): Nave Ruediger, Fisher Robyn, McCracken Nigel
Primary Institution: Nycomed GmbH
Hypothesis
The metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in the lung is considerably different.
Conclusion
The in vitro metabolic pathways of the tested inhaled corticosteroids in human lung tissue were differing, with fluticasone propionate being metabolically stable and the majority of beclomethasone dipropionate converted to inactive metabolites.
Supporting Evidence
- Beclomethasone dipropionate was hydrolyzed to both active and inactive metabolites.
- Ciclesonide was metabolized to its active form, desisobutyryl-ciclesonide.
- Fluticasone propionate showed no detectable metabolites, indicating metabolic stability.
Takeaway
This study looked at how different asthma medications are broken down in the lungs, finding that some are more effective than others at staying active.
Methodology
Lung tissue slices were incubated with various corticosteroids, and their metabolites were analyzed using HPLC.
Potential Biases
Potential bias due to the involvement of employees from the sponsoring company in the study.
Limitations
The study used a high initial concentration of drugs that may not reflect typical clinical doses.
Participant Demographics
[{"age":19,"sex":"Male","race":"Hispanic"},{"age":48,"sex":"Male","race":"Caucasian"},{"age":43,"sex":"Female","race":"Caucasian"}]
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website